跳至主要内容
临床试验/NCT03365856
NCT03365856Unknown不适用

Remission in Rheumatoid Arthritis in the Asian-Pacific Region

Peking University People's Hospital0 个研究点目标入组 1,500 人开始时间: 2018年1月1日最近更新:
适应症

试验速览

阶段
不适用
入组人数
1,500
主要终点
remission rate of RA patients in different countries in the Asian-Pacific area

研究概览

简要总结

This study is the multi-center, open and cross-sectional study of RA remission in Asia Pacific region. The objectives is to explore remission rate of RA patients in different countries in the Asian-Pacific area using different criteria of remission (DAS28, CDAI, SDAI, ACR/EULA remission criteria, RAPID3 and Clin28) and investigate the associated factors of remission in RA patients.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • RA patients fulfilled the American College of Rheumatology 1987 criteria or the 2010 ACR/EULAR classification criteria.
  • Patients aged > 18 years.

排除标准

  • 未提供

结局指标

主要结局

remission rate of RA patients in different countries in the Asian-Pacific area

时间窗: 12-24 months

according to the different criteria of clinical remission in RA patients

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

相似试验